1887

Abstract

A total of 2120 nucleotide sequences of the NS5b region of HCV subtype 3a were analysed, including 310 strains derived from former republics of the USSR (Azerbaijan, Estonia, Lithuania, Russia, Tajikistan and Uzbekistan). Among the viral isolates collected from former regions of the Soviet Union, 294 strains formed 3 sustained phylogenetic clusters, with each having a common origin. Phylodynamic analysis demonstrated that the most recent common ancestors of the current strains inside the three clusters were introduced into the USSR population in 1981±1, 1984±2 and 1985±2, respectively (the confidence intervals were calculated using Student's t-distribution, P<0.05). The time estimation obtained for HCV subtype 3a correlated well with the historical and epidemiological context of this period, and in particular with the start of widespread injection drug use in the USSR in the first half of the 1980s.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000878
2017-07-26
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/98/8/2079.html?itemId=/content/journal/jgv/10.1099/jgv.0.000878&mimeType=html&fmt=ahah

References

  1. Gray RR, Parker J, Lemey P, Salemi M, Katzourakis A et al. The mode and tempo of hepatitis C virus evolution within and among hosts. BMC Evol Biol 2011;11:131–141 [CrossRef][PubMed]
    [Google Scholar]
  2. Zehender G, Sorrentino C, Lai A, Ebranati E, Gabanelli E et al. Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region. Infect Genet Evol 2013;17:223–230 [CrossRef][PubMed]
    [Google Scholar]
  3. Mcnaughton AL, Cameron ID, Wignall-Fleming EB, Biek R, Mclauchlan J et al. Spatiotemporal reconstruction of the introduction of hepatitis C virus into Scotland and its subsequent regional transmission. J Virol 2015;89:11223–11232 [CrossRef][PubMed]
    [Google Scholar]
  4. Magiorkinis G, Magiorkinis E, Paraskevis D, Ho SY, Shapiro B et al. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 2009;6:e1000198 [CrossRef][PubMed]
    [Google Scholar]
  5. Iles JC, Raghwani J, Harrison GL, Pepin J, Djoko CF et al. Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa. Virology 2014;464-465:233–243 [CrossRef][PubMed]
    [Google Scholar]
  6. Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014;59:318–327 [CrossRef][PubMed]
    [Google Scholar]
  7. Simmonds P, Bukh J, Combet C, Deléage G, Enomoto N et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962–973 [CrossRef][PubMed]
    [Google Scholar]
  8. Bukh J. The history of hepatitis C virus (HCV): basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control. J Hepatol 2016;65:S2–S21 [CrossRef][PubMed]
    [Google Scholar]
  9. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008;48:148–162 [CrossRef][PubMed]
    [Google Scholar]
  10. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int 2011;31:30–60 [CrossRef][PubMed]
    [Google Scholar]
  11. Kuiken C, Yusim K, Boykin L, Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005;21:379–384 [CrossRef][PubMed]
    [Google Scholar]
  12. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 1985;39:783–791 [CrossRef][PubMed]
    [Google Scholar]
  13. Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol 2012;29:1969–1973 [CrossRef][PubMed]
    [Google Scholar]
  14. Henquell C, Guglielmini J, Verbeeck J, Mahul A, Thibault V et al. Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study. Infect Genet Evol 2011;11:496–503 [CrossRef][PubMed]
    [Google Scholar]
  15. Hordijk W, Gascuel O. Improving the efficiency of SPR moves in phylogenetic tree search methods based on maximum likelihood. Bioinformatics 2005;21:4338–4347 [CrossRef][PubMed]
    [Google Scholar]
  16. Anisimova M, Gil M, Dufayard JF, Dessimoz C, Gascuel O. Survey of branch support methods demonstrates accuracy, power, and robustness of fast likelihood-based approximation schemes. Syst Biol 2011;60:685–699 [CrossRef][PubMed]
    [Google Scholar]
  17. L'Vov DK, Samokhvalov EI, Mishiro S, Tsuda F, Selivanov NA et al. Regularities in the spread of hepatitis C virus and its genotypes in Russian and countries within the former USSR. Vopr Virusol 1997;42:157–161[PubMed]
    [Google Scholar]
  18. Kalinina O, Norder H, Vetrov T, Zhdanov K, Barzunova M et al. Shift in predominating subtype of HCV from 1b to 3a in St. Petersburg mediated by increase in injecting drug use. J Med Virol 2001;65:517–524 [CrossRef][PubMed]
    [Google Scholar]
  19. Shustov AV, Kochneva GV, Sivolobova GF, Grazhdantseva AA, Gavrilova IV et al. Molecular epidemiology of the hepatitis C virus in Western Siberia. J Med Virol 2005;77:382–389 [CrossRef][PubMed]
    [Google Scholar]
  20. Babaian EA. Drug addiction control in the USSR. Bull Narc 1971;23:1–2
    [Google Scholar]
  21. The USSR and Illicit Drugs: Facing Up to the Problem 1986; CIA Historical Review Program [online]. Available at:www.cia.gov/library/readingroom/docs/DOC_0000500703.pdf
  22. Babayan EA. The legal regulation of narcotic drugs and psychotropic substance in the Union of Soviet Socialist Republics. Bull Narc 1990;1:73–81
    [Google Scholar]
  23. Neuhauser KC. The market for illegal drugs in the Soviet Union in the late 1980s. Berkley-Duke Occasional Papers on the Second Economy in the USSRvol. 23 1990; pp.1–94
    [Google Scholar]
  24. Knyazev A. To the History and Present State of Drug Production in Afghanistan, and Their Distribution in Central Asia Bishkek (In Russian): Ilim; 2003
    [Google Scholar]
  25. Pybus OG, Cochrane A, Holmes EC, Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 2005;5:131–139 [CrossRef]
    [Google Scholar]
  26. Stikleryte A, Griskeviciene J, Magnius LO, Zagminas K, Norder H et al. Characterization of HCV strains in an oncohematological pediatric department reveals little horizontal transmission but multiple introductions by un-screened blood products in the past. J Med Virol 2006;78:1411–1422 [CrossRef][PubMed]
    [Google Scholar]
  27. Tallo T, Norder H, Tefanova V, Krispin T, Schmidt J et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007;79:374–382 [CrossRef][PubMed]
    [Google Scholar]
  28. Zhang C, Wu N, Liu J, Ge Q, Huang Y et al. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS One 2011;6:e16817 [CrossRef][PubMed]
    [Google Scholar]
  29. Demetriou VL, van de Vijver DA, Kostrikis LG. Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol 2009;81:238–248 [CrossRef][PubMed]
    [Google Scholar]
  30. Kalinina O, Norder H, Mukomolov S, Magnius LO. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002;76:4034–4043 [CrossRef][PubMed]
    [Google Scholar]
  31. Kurbanov F, Tanaka Y, Avazova D, Khan A, Sugauchi F et al. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 2008;38:457–464 [CrossRef][PubMed]
    [Google Scholar]
  32. Kurbanov F, Tanaka Y, Chub E, Maruyama I, Azlarova A et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis 2008;198:1448–1456 [CrossRef][PubMed]
    [Google Scholar]
  33. Chub EV, Kochneva GV, Granirov VM, Netesov SV. Type 2k/1b recombinants of hepatitis C virus among the population of Altai region. Infect Dis 2007;5:5–11
    [Google Scholar]
  34. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30:2725–2729 [CrossRef][PubMed]
    [Google Scholar]
  35. Yanagi M, Purcell RH, Emerson SU, Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci USA 1997;94:8738–8743 [CrossRef][PubMed]
    [Google Scholar]
  36. Felsenstein J. PHYLIP (Phylogeny Inference Package) Version 3.6a3 Seattle: University of Washington; 2002
    [Google Scholar]
  37. Tanaka T, Kato N, Hijikata M, Shimotohno K. Base transitions and base transversions seen in mutations among various types of the hepatitis C viral genome. FEBS Lett 1993;315:201–203 [CrossRef][PubMed]
    [Google Scholar]
  38. Shapiro B, Rambaut A, Drummond AJ. Choosing appropriate substitution models for the phylogenetic analysis of protein-coding sequences. Mol Biol Evol 2006;23:7–9 [CrossRef][PubMed]
    [Google Scholar]
  39. Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M et al. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan. J Med Virol 2008;80:268–276 [CrossRef][PubMed]
    [Google Scholar]
  40. Tanaka Y, Kurbanov F, Mano S, Orito E, Vargas V et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology 2006;130:703–714 [CrossRef][PubMed]
    [Google Scholar]
  41. Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Kostrikis LG. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus. J Med Virol 2010;82:263–270 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000878
Loading
/content/journal/jgv/10.1099/jgv.0.000878
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error